Financials Evolva Holding SA

Equities

EVE

CH1262055788

Biotechnology & Medical Research

Market Closed - Swiss Exchange 11:31:30 2024-04-26 am EDT 5-day change 1st Jan Change
0.946 CHF -6.34% Intraday chart for Evolva Holding SA +0.42% +31.39%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 177.1 169.5 157.3 127 91.05 4.903
Enterprise Value (EV) 1 119.9 135.7 146.6 126.8 101 -0.9356
P/E ratio -6.07 x -7.8 x -5.32 x -2.86 x -2.02 x -0.05 x
Yield - - - - - -
Capitalization / Revenue 19.8 x 14.6 x 20.9 x 12.9 x 5.86 x 1.18 x
EV / Revenue 13.4 x 11.7 x 19.4 x 12.8 x 6.5 x -0.23 x
EV / EBITDA -5.13 x -10.1 x -9.6 x -4.92 x -6.09 x -0.16 x
EV / FCF -7.08 x -9.55 x -8.91 x -4.95 x -9.26 x -0.06 x
FCF Yield -14.1% -10.5% -11.2% -20.2% -10.8% -1,773%
Price to Book 0.91 x 0.98 x 1.12 x 1.01 x 0.86 x 0.94 x
Nbr of stocks (in thousands) 3,079 3,095 3,114 3,791 4,441 6,810
Reference price 2 57.50 54.75 50.50 33.50 20.50 0.7200
Announcement Date 2/28/19 3/18/20 2/25/21 3/10/22 3/8/23 3/22/24
1CHF in Million2CHF
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 8.933 11.6 7.541 9.878 15.54 4.157
EBITDA 1 -23.35 -13.43 -15.27 -25.78 -16.57 5.711
EBIT 1 -30.74 -20.13 -22 -31.9 -21.77 0.5062
Operating Margin -344.08% -173.57% -291.81% -322.96% -140.12% 12.18%
Earnings before Tax (EBT) 1 -31.32 -21.61 -29.89 -41.41 -43.37 -101.2
Net income 1 -29.21 -21.64 -29.87 -41.27 -43.37 -101.2
Net margin -327.04% -186.61% -396.12% -417.78% -279.07% -2,434.99%
EPS 2 -9.478 -7.022 -9.491 -11.72 -10.13 -14.04
Free Cash Flow 1 -16.93 -14.21 -16.46 -25.6 -10.9 16.59
FCF margin -189.55% -122.52% -218.27% -259.18% -70.14% 399.04%
FCF Conversion (EBITDA) - - - - - 290.42%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/28/19 3/18/20 2/25/21 3/10/22 3/8/23 3/22/24
1CHF in Million2CHF
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 S1
Net sales 1 4.5
EBITDA 1 -6.3
EBIT 1 -9.8
Operating Margin -217.78%
Earnings before Tax (EBT) -
Net income -
Net margin -
EPS -
Dividend per Share -
Announcement Date 8/23/23
1CHF in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - 9.91 -
Net Cash position 1 57.2 33.8 10.6 0.16 - 5.84
Leverage (Debt/EBITDA) - - - - -0.5984 x -
Free Cash Flow 1 -16.9 -14.2 -16.5 -25.6 -10.9 16.6
ROE (net income / shareholders' equity) -14.1% -11.8% -18.8% -29.8% -36.4% -181%
ROA (Net income/ Total Assets) -8.48% -6.21% -7.66% -12.3% -9.48% 0.45%
Assets 1 344.3 348.4 389.8 334.3 457.6 -22,532
Book Value Per Share 2 63.00 55.60 45.00 33.10 23.80 0.7700
Cash Flow per Share 2 19.60 12.90 6.100 2.760 1.150 0.8100
Capex 1 0.89 0.19 1.23 0.34 0.49 -
Capex / Sales 9.95% 1.67% 16.28% 3.39% 3.17% -
Announcement Date 2/28/19 3/18/20 2/25/21 3/10/22 3/8/23 3/22/24
1CHF in Million2CHF
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. EVE Stock
  4. Financials Evolva Holding SA